Skip to main content

Main menu

  • Home
  • About
    • Our Management
    • Investors
    • Our Methodology
    • Intellectual Property
    • Publications
    • Technology
  • Services
    • SistemRNA™
    • SistemQC™
    • SistemTox™
    • SistemKB™
    • SistemBM™
    • SistemSeek™
    • Case Studies
      • Comparability Testing
      • Donor Selection
      • Surrogate Potency Testing
  • News
  • Contact Us

Search form

Home
Previous Pause Next

Current Location

HomeServicesCase Studies

Comparability Testing

Please check back soon for our case studies!

Navigation

  • SistemRNA™
  • SistemQC™
  • SistemTox™
  • SistemKB™
  • SistemBM™
  • SistemSeek™
  • Case Studies
    • Comparability Testing
    • Donor Selection
    • Surrogate Potency Testing

Events & Meetings

  • microRNA as Biomarkers and Diagnostics 
    • Arrange a meeting
  • ISCT
    • Arrange a meeting
  • Bio-IT World Expo
    • Arrange a meeting

Recent News

International Society of Cellular Therapy: 23rd - 26th April

Release Date: March 19, 2014

#222222">We are delighted to confirm our attendance to the 20th Annual Meeting for the International Society of Cellular Therapy in Paris from April 23rd to the 26th.

Season's Greeting from Sistemic

Release Date: December 24, 2013
The holiday season is upon us and Sistemic would like to take a moment to thank all of our collaborators, colleagues, clients and friends for a rewarding and productive year.
 
We hope you have an enjoyable holiday period and we hope to continue to work with you in 2014.
 

NHS Scotland and Sistemic Collaborate to develop novel early diagnostics for Diabetic sight loss

Release Date: October 25, 2013
 
Sistemic Limited, the Glasgow and Boston-based leader in the field of micro RNA (miRNA) analysis, today announced an agreement with NHS Scotland, supported by Health  Sciences Scotland to work together to in the area of Stratified Medicine to develop novel diagnostic biomarkers for the early detection of diabetic retinopathy and infective keratitis patients.

Sistemic and QCMD announce an innovative collaboration aimed at addressing the need for quality assurance and standardisation in the cell therapy

Release Date: October 15, 2013

Sistemic Ltd and QCMD Ltd (Quality Control for Molecular Diagnostics) announced today that the companies had entered into a cross-licensing agreement.

Scotland demonstrates its collaborative approach to cell therapy development

Release Date: October 15, 2013

Leading industry players, Sistemic and Roslin Cells, are going to work together with Scottish Development International (SDI) to make the process of undertaking clinical trials in cell therapy easier, faster and more successful in reaching commercial realisation.

Previous Pause Next

Applications & Case Studies

  • Donor Selection
  • Comparability Testing
  • Surrogate Potency Testing

Recent Tweets

Season's Greetings and Happy Holidays Despite the extraordinary challenges this year has brought to us all, we wou… https://t.co/om5MRi0VuS — Tweeted: Tue, 12/22/2020 - 11:54
Reply Retweet Favorite
Sistemic Ltd announce expansion of patent portfolio covering the use of microRNAs as predictive analytes for cellul… https://t.co/zuD3RS8khe — Tweeted: Thu, 07/16/2020 - 11:42
Reply Retweet Favorite
We are happy to announce that as of 9.00am (BST) 15/04/20, Sistemic is open again. We have taken steps to allow all… https://t.co/RxOUPmoD13 — Tweeted: Wed, 04/15/2020 - 11:28
Reply Retweet Favorite
RT @RegMedNet: Could #pluripotency ruin your #celltherapy? Read about the current state of the field and how you can avoid residual #ipsc w… — Tweeted: Thu, 04/09/2020 - 15:50
Reply Retweet Favorite
Sistemic are delighted to announce a new article published on RegMedNet titled “In vitro assays for residual plurip… https://t.co/nMogJdhDAm — Tweeted: Mon, 03/30/2020 - 11:18
Reply Retweet Favorite
As a consequence of the most recent UK and Scottish Governments enforced measures, Sistemic will close at the end o… https://t.co/CsuljoOZmE — Tweeted: Wed, 03/25/2020 - 12:42
Reply Retweet Favorite
#CoronaVirusUpdate can be found on our website! We appreciate your patience at this time and please stay safe. https://t.co/pbjiLI2Cul — Tweeted: Fri, 03/20/2020 - 11:42
Reply Retweet Favorite
Season's Greetings and Happy Holidays! We would just like to take a moment to thank all of our clients, colleagues… https://t.co/OLdUA5CnU1 — Tweeted: Wed, 12/18/2019 - 11:41
Reply Retweet Favorite
A great two days at ‘Safety of Stem Cell-Derived Therapies: Trends in Future Technologies’ in Edinburgh that Sistem… https://t.co/qSWjmgzLb1 — Tweeted: Thu, 10/10/2019 - 16:43
Reply Retweet Favorite
Sistemic will be attending Safety of Stem Cell-Derived Therapies https://t.co/mguRxd8TbR https://t.co/ZIowq7x4JB — Tweeted: Wed, 10/02/2019 - 10:38
Reply Retweet Favorite
EPO granted Sistemic the Patent covering the use of microRNAs for quality assessment of stem cell therapy products https://t.co/diZeCjyi54 — Tweeted: Thu, 03/28/2019 - 15:55
Reply Retweet Favorite
The successful development of Sistemic’s SistemPSCCheck™ assay is featured as case studies on both the Innovate UK… https://t.co/a3NmnCG4p6 — Tweeted: Mon, 03/25/2019 - 14:49
Reply Retweet Favorite
Sistemic Ltd announce expansion of patent portfolio covering the use of microRNAs for quality assessment of stem ce… https://t.co/S6JAxxx3rM — Tweeted: Mon, 01/28/2019 - 16:27
Reply Retweet Favorite
Sistemic Announce Global Service and License Agreement for SistemPSCCheck™ https://t.co/zjJDlP8dqD https://t.co/7kRf6DJxzp — Tweeted: Mon, 10/22/2018 - 16:24
Reply Retweet Favorite
We are hiring! Product Service Support Position (Placement ID: CJCTGUEKKF): https://t.co/sERDjHVqaY R&D Support P… https://t.co/clwUaYy7dV — Tweeted: Fri, 09/28/2018 - 17:11
Reply Retweet Favorite
We are attending this years fourth annual Cell Therapy Conference to talk about SistemPSCCheck: https://t.co/l1JzaLJPBw — Tweeted: Mon, 06/04/2018 - 22:02
Reply Retweet Favorite
We'll be attending the 4th Cell Therapy Conference in Los Angeles from the 4th-6th. Contact for partnering. — Tweeted: Fri, 06/01/2018 - 11:02
Reply Retweet Favorite
Meet us at Phacilitate Cell & Gene Therapy World and the World Stem Cell Summit to discuss our assay for assessment… https://t.co/bcZLrYWdSG — Tweeted: Wed, 01/17/2018 - 16:23
Reply Retweet Favorite
Sistemic announce significant progress of PSC contamination detection technology in derived #celltherapy products https://t.co/6T1HDInrTb — Tweeted: Wed, 10/04/2017 - 14:03
Reply Retweet Favorite
We will be attending this years @alliancerm 2017 Cell & Gene Meeting on the Mesa - DM for partnering information! #mesa17 — Tweeted: Tue, 10/03/2017 - 10:36
Reply Retweet Favorite
We are excited to confirm our attendance to #ISCT 2014. Read more about our posters here: http://t.co/udAjzyowlZ — Tweeted: Wed, 03/19/2014 - 09:51
Reply Retweet Favorite
@_JulieNixon we're looking forward to it.. and it's not just the pizza making us say that! — Tweeted: Wed, 01/15/2014 - 11:33
Reply Retweet Favorite
We would like to wish all of our American colleagues, collaborators and friends a very happy Thanksgiving! — Tweeted: Thu, 11/28/2013 - 15:44
Reply Retweet Favorite
We're presenting @EdinburghBQ today! If you're in the area swing by and say hello. — Tweeted: Wed, 11/27/2013 - 10:23
Reply Retweet Favorite
RT @SULSAtweets: @Sistemic presents their miRNA analysis platform @HealthSciScot event @EdinburghBQ with applications in stem cell research. — Tweeted: Wed, 11/27/2013 - 10:14
Reply Retweet Favorite
NHS Scotland and Sistemic Collaborate to develop novel early diagnostics for Diabetic sight loss http://t.co/u5yNsM1dCd #diabetes #mirna RT — Tweeted: Tue, 10/29/2013 - 18:12
Reply Retweet Favorite
As #StemCells Meeting on the Mesa 2013 draws to an end we would just like to thank everyone for the enjoyable and productive week! #SCMOM13 — Tweeted: Fri, 10/18/2013 - 16:40
Reply Retweet Favorite
RT @RoslinCells: #Scottish companies leading the way in #celltherapy development http://t.co/GzxxPM4F0W @ScotDevInt @Sistemic @scotent @CTC… — Tweeted: Fri, 10/18/2013 - 12:35
Reply Retweet Favorite
Here's another infographic showing the key points of our recently announced collaboration with QCMD! #SCMOM13 http://t.co/D63mTOCbCL — Tweeted: Wed, 10/16/2013 - 17:03
Reply Retweet Favorite
We're excited to announce collab between Sistemic and QCMD aimed at ensuring standards in #celltherapy. Full story: http://t.co/1NAM9m7Oc6 — Tweeted: Wed, 10/16/2013 - 14:53
Reply Retweet Favorite
If you missed our earlier announcements then here's a quick recap in infographic form: #SCMOM13 RT http://t.co/axJG940thO — Tweeted: Tue, 10/15/2013 - 16:55
Reply Retweet Favorite
Our new partnership with @RoslinCells helps make Scotland the best destination for CT clinical trials. Full story: http://t.co/4Lp0crUexR — Tweeted: Tue, 10/15/2013 - 11:31
Reply Retweet Favorite
RT @ScotDevInt: Conducting clinical trials in Scotland to get easier thks to a new industry partnership.@Sistemic @RoslinCells http://t.co… — Tweeted: Tue, 10/15/2013 - 10:23
Reply Retweet Favorite
We're having a great time at this years Stem Cells Meeting on the Mesa! Some announcements to follow soon! #SCMOM13 — Tweeted: Tue, 10/15/2013 - 09:22
Reply Retweet Favorite
We will be attending the Regenerative Medicine Manufacturing Industrial Summit on the 13th of September. Hope to see you there! — Tweeted: Thu, 09/12/2013 - 11:41
Reply Retweet Favorite
Sistemic is delighted to be attending ISSCR. Come and see us on the 12th of June at the poster W-2046 or ask for us at the SDI booth! — Tweeted: Wed, 06/12/2013 - 00:32
Reply Retweet Favorite
We would like to offer our deepest sympathy to all our friends and colleagues in Boston and the Massachusetts area. — Tweeted: Tue, 04/16/2013 - 10:48
Reply Retweet Favorite
Sistemic & leading CDMO, Progenitor Cell Therapy initiate study on novel stem cell characterisation technology http://t.co/ikrRmG7Cg8 — Tweeted: Thu, 03/14/2013 - 15:19
Reply Retweet Favorite
Harvard licenses stem cell assays to Life Technologies http://t.co/gC5dG6FLee — Tweeted: Tue, 03/05/2013 - 16:45
Reply Retweet Favorite
Kan. bill would establish adult stem cell facility moves forward http://t.co/00TKdAvYMJ — Tweeted: Fri, 03/01/2013 - 10:28
Reply Retweet Favorite
StemBioSys raises $2M for stem cell culturing technique http://t.co/GTAIIQhZMf — Tweeted: Tue, 02/26/2013 - 09:23
Reply Retweet Favorite
NIH awards stem cell contract to Lonza http://t.co/K3ntwv42pH — Tweeted: Fri, 02/22/2013 - 16:55
Reply Retweet Favorite
ViaCyte wins $6M to advance stem cell treatment for diabetes http://t.co/4tl8mFbA — Tweeted: Fri, 02/15/2013 - 16:11
Reply Retweet Favorite
FDA approves clinical testing of stem cell-based myopia treatment http://t.co/NZa6wQMa — Tweeted: Fri, 02/15/2013 - 11:32
Reply Retweet Favorite
Stem cells survive being "printed" in 3D pattern http://t.co/QixZUFgS — Tweeted: Fri, 02/08/2013 - 16:13
Reply Retweet Favorite
StemEx lowers mortality rate in patients with blood cancers http://t.co/3jUUHijD — Tweeted: Wed, 02/06/2013 - 15:39
Reply Retweet Favorite
Antibody Based Therapeutics - Programme http://t.co/F8Gas10Y — Tweeted: Tue, 01/22/2013 - 22:34
Reply Retweet Favorite
Institute prepares for production of RBCs from stem cells http://t.co/EBUiNCrT — Tweeted: Wed, 01/16/2013 - 16:14
Reply Retweet Favorite
AstraZeneca signs stem cell collaboration with Cellular Dynamics http://t.co/fAjW4KtO — Tweeted: Mon, 01/07/2013 - 09:53
Reply Retweet Favorite
Cellular Dynamics to produce stem cell-based assays for research http://t.co/TxkVdRn1 — Tweeted: Fri, 12/21/2012 - 11:24
Reply Retweet Favorite
Stem cell vet ACT aims for pioneering human trial of iPS-cell-derived therapy - FierceBiotech: http://t.co/BS9dwj9h — Tweeted: Thu, 12/20/2012 - 12:41
Reply Retweet Favorite
Advanced Cell seeks FDA OK for trial of stem cell-based platelets http://t.co/pnSTDrxZ — Tweeted: Mon, 12/17/2012 - 15:55
Reply Retweet Favorite
Natural cure: Scientists create stem cell contact lens http://t.co/NRfRrxUR via @sharethis — Tweeted: Tue, 12/11/2012 - 16:00
Reply Retweet Favorite
Stem cell bank (StemBANCC) aims to speed drug development http://t.co/ihPVzi7W via @sharethis — Tweeted: Tue, 12/11/2012 - 15:58
Reply Retweet Favorite
Previous Pause Next

Our Products

  • SistemRNA™
  • SistemQC™
  • SistemSeek™
  • SistemTox™
  • SistemKB™

Sistemic’s platform technology pioneering the approach and development of miRNA-based profiling tools to guide and support Cell Therapy (CT) product development and drug discovery and repositioning

Allows for robust miRNA profiling, customised multi-layered statistical analysis, and biological interpretation and identification of the key markers (KmiR’s™) of cell phenotype. Whilst also seeking to maximise the utility and value of the KmiR’s™ identified

Sistemic’s proprietary literature mining tool which searches NCBI Medline for co-citation of microRNA and user-defined biological terms. Search outputs are stored in a relational curated database which can provide insights target systems.

Sistemic's methodologies can also be applied to define, qualify and validating miRNA biomarkers from biofluids and surgical samples for prediction, diagnostic, prognostic, monitoring, toxicity and end-point.

Sistemic’s highly curated knowledge from internal and external projects covering miRNA and cell therapy-based knowledge. The database includes kmiR™ lists from all analyses and high impact meta-data. The knowledgebase is fully integrated with SistemSeek™ literature database

Social Media

To find out more about Sistemic follow us on social media:

Follow @Sistemic
Google+

Copyright © 2013, Sistemic Scotland Limited. All Rights Reserved. Terms and Conditions Apply.